Acrivon Therapeutics, Inc. (ACRV) vs ANIXA BIOSCIENCES INC (ANIX)

Acrivon Therapeutics, Inc. and ANIXA BIOSCIENCES INC are both Biotechnology companies. Acrivon Therapeutics, Inc. and ANIXA BIOSCIENCES INC are of similar size ($96.6M and $90.9M). Across the 8 metrics below, Acrivon Therapeutics, Inc. leads on 4 and ANIXA BIOSCIENCES INC on 4.

Valuation

Metric ACRV ANIX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 97.76 11.47
P/B 1.01 7.20 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.03 n/m 0.74
EV/Sales n/m 85.36 10.73
Earnings yield (89.52%) (11.51%) (28.84%)
Free cash flow yield (72.99%) (7.73%) (23.03%)

Profitability

Metric ACRV ANIX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.63%) (72.57%) (57.72%)
Return on assets (57.61%) (63.45%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACRV ANIX Biotechnology median
Revenue growth (TTM) — (34.10%) 5.64%
EPS growth (last fiscal year) 15.13% 12.82% —
Revenue growth, 5-year CAGR — (6.89%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRV ANIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 8.55 4.73
Net debt to EBITDA 1.43 1.29 0.96

Dividend

Metric ACRV ANIX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ACRV ANIX Biotechnology median
Market cap 90.85m 96.64m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack